Felbamate and Weakness - a phase IV clinical study of FDA data

Summary:

Weakness is reported as a side effect among people who take Felbamate (felbamate), especially for people who are male, 2-9 old, also take Epidiolex, and have Lennox-gastaut syndrome.

The phase IV clinical study analyzes which people have Weakness when taking Felbamate. It is created by eHealthMe based on reports of 1,140 people who have side effects when taking Felbamate from the FDA, and is updated regularly.

What is Felbamate?

Felbamate has active ingredients of felbamate. eHealthMe is studying from 1,145 Felbamate users. Check the latest studies of Felbamate.

What is Weakness?

Weakness is found to be associated with 3,640 drugs and 6,612 conditions by eHealthMe. Check the latest studies of Weakness.

On Jul, 09, 2026

1,140 people reported to have side effects when taking Felbamate.
Among them, 14 people (1.23%) have Weakness.

Among these 14 people:

What is the gender of people who have Weakness when taking Felbamate? *

female: 16.67 %
male: 83.33 %

What is the age of people who have Weakness when taking Felbamate? *

What are other drugs people take besides Felbamate? *

What are other side effects people have besides Weakness? *

Seizures (abnormal excessive or synchronous neuronal activity in the brain): 6 people, 42.86%
Fatigue (feeling of tiredness): 5 people, 35.71%
Hypophagia (reduced food intake): 4 people, 28.57%
Drowsiness: 4 people, 28.57%
Balance Disorder: 4 people, 28.57%
Feeling Abnormal: 3 people, 21.43%
Pain: 2 people, 14.29%
Emotional Distress: 2 people, 14.29%
Vision Blurred: 2 people, 14.29%
Drug Ineffective: 2 people, 14.29%

What are the existing conditions these people have? *

Seizures (abnormal excessive or synchronous neuronal activity in the brain): 7 people, 50.00%
Lennox-Gastaut Syndrome (epilepsy characterized by frequent seizures and different seizure types): 7 people, 50.00%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 6 people, 42.86%
Aggression: 3 people, 21.43%
Thyroid Diseases: 1 person, 7.14%
Respiratory Disorder (respiratory disease): 1 person, 7.14%
Psychotic Disorder: 1 person, 7.14%
Psychiatric Symptom: 1 person, 7.14%
Pneumonia Pseudomonal (pseudomonas pneumonia is an infection caused by the microbe known as pseudomonas aeruginosa): 1 person, 7.14%
Developmental Delay: 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Felbamate and have Weakness?

- Check whether Weakness is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Felbamate:

Felbamate (1,145 reports)

Weakness treatments and more:

Weakness (586,876 reports)

Browse all side effects of Felbamate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Weakness:

Weakness (3,640 drugs)

Browse all the conditions that are associated with Weakness:

Weakness (6,612 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on felbamate (the active ingredients of Felbamate) and Felbamate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.